Loading
NASDAQHealthcareBiotechnology
Latest quote
$10.09
−$0.68 · -6.31%
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
Regular session
$10.09
−$0.68 · -6.31%
Regular session · ET · Market data may be delayed.
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
Day range
Current $10.09
52-week range
Current $10.09
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
31
Expensive
Sentiment
47
Mixed
Risk
66
High Risk
Momentum
80
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
Day range
Current $10.09
52-week range
Current $10.09
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of goods sold | 2.62M USD | — | — | — | 4.97K USD |
| Gross profit | −2.62M USD | — | — | — | −4.97K USD |
| Research and development | 202.86M USD | 112.77M USD | 31.8M USD | 42.05M USD | 35.52M USD |
| Selling, general, and administrative | 41.97M USD | 30.32M USD | 22.32M USD | 23.01M USD | 18.05M USD |
| Operating expenses | 242.22M USD | 143.09M USD | 54.12M USD | 65.06M USD | 53.57M USD |
| Interest expense | 7.25M USD | — | — | — | — |
| Depreciation and amortization | 2.62M USD | 1.38M USD | 370K USD | 164.78K USD | 4.97K USD |
| Operating income | −244.83M USD | −143.09M USD | −54.12M USD | −65.06M USD | −53.58M USD |
| Net income | −227.32M USD | −118.94M USD | −36.01M USD | −49.97M USD | −53.64M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
T. Rowe Capital Appreciation Equity ETFTCAF2.64M0.03%9.09B USD0.31%$43.075-0.86%
Vanguard Health Care ETFVHT2.03M0.01%22B USD0.09%$312.32-0.95%
iShares ESG Aware MSCI USA Small-Cap ETFESML940.07K0.03%2.77B USD0.17%$52.275-0.09%
Nuveen ESG Small-Cap ETFNUSC456.06K0.04%1.25B USD0.31%$48.885+0.07%
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMED449.68K1.39%32.37M USD0.44%$32.915-0.86%
State Street SPDR S&P International Small Cap ETFGWX414.08K0.04%925.91M USD0.40%$45.055-0.93%
Optimize Strategy Index ETFOPTZ346.3K0.13%270.89M USD0.25%$45.679-0.91%
Fidelity Nasdaq Composite Index ETFONEQ338.04K—10.94B USD0.21%$106.89-1.44%T. Rowe Capital Appreciation Equity ETFTCAFVanguard Health Care ETFVHTiShares ESG Aware MSCI USA Small-Cap ETFESMLNuveen ESG Small-Cap ETFNUSCT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMEDState Street SPDR S&P International Small Cap ETFGWXOptimize Strategy Index ETFOPTZFidelity Nasdaq Composite Index ETFONEQAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
